BeStock  
Markets › Compare › INVA vs RAPP

INVA vs RAPP

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
INVA · Innoviva$18.41 ▲ 0.00%
RAPP · Rapport Therapeutics$23.16 ▼ 1.82%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

73103132162192Nov 24, '25May 26, '26Nov 20, '26
  • INVA -13.5%
  • RAPP -18.2%

Head to head

MetricINVARAPP
Price$18.41$23.16
Change today▲ 0.00%▼ 1.82%
Market cap$1.31B$1.37B
Return, 3 months-12.5%-53.1%
Return, year to date-7.9%-23.7%
Return, 1 year-12.2%-15.0%
P/E (TTM)7.8–
P/B1.23.5
P/E percentile vs own 5y61st73rd
Dividend yield––
Revenue growth (YoY, latest qtr)-1.6%–
Net profit growth (YoY)-182.2%-49.4%
Gross margin80.5%–
Operating margin38.8%-838.1%
Net margin44.1%-752.4%
Return on equity18.0%-33.3%
Analyst target vs. price+106.4%+193.6%
Analyst buy share100%100%
RSI (14)2937
30-day volatility34.7%99.9%
Max drawdown, 1 year-24.5%-57.1%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • RAPP is the largest of the group by market value.
  • INVA has returned the most over the past year.
  • INVA keeps the most profit per dollar of sales.
  • INVA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top